Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (CSE: $IAN.C) (CSE: $ABCS.C) (CSE: $GGB.C) (TSX: $VFF.TO) (NASDAQ: $VFF) (TSXV: $N.V)
Delta, Kelowna, BC –July 11, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/07111JAN-ABCS-GGB-VFF-N.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
CBD For Life, a subsidiary of iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, announced that it is continuing to expand its retail presence with a partnership with Dillard's, Inc.
The Company's CBD-infused wellness, self-care, and beauty products are currently available throughout Dillard's 265 department stores spanning 29 states—with initial purchase orders received for a range of CBD For Life's products including pure CBD rubs, roll-on oils, eye serum, face and body cleanser, hand and body massage lotion, as well as CBD-infused bath bombs, just to name a few. The Company's products are also available for purchase on the Dillard's website at www.Dillards.com/brand/CBD+For+Life.
"We're excited for our products to be featured on the shelves of one of the largest and most well-regarded fashion retailers in the United States," said Beth Stavola, Co-Founder of CBD For Life and Chief Strategy Officer of iAnthus. "The ability to reach an even broader audience via the well-established customer base of a great partner like Dillard's brings us another step closer to achieving our end goal of establishing CBD For Life as a household name in beauty and wellness."
Abacus Health Products (CSE: ABCS) today announced new retail purchase orders for its line of CBDMEDIC™ products, which are sold to consumers via retail chains and the company's e-commerce platform.
Abacus is proud to announce the Company has received purchase orders from CVS (NYSE: CVS) to carry two of its new CBDMEDIC™ dermatology products for Eczema and Itch & Rash in over 400 stores. Furthermore, these two products plus an additional eight CBDMEDIC pain products will move in-line in over 600 stores. In-line is where products are sold on the shelf according to their applicable category section. For example, these eight pain products will be added to the analgesic section of the store.
"We are encouraged to see the continued interest and growth in CBDMEDIC™ among leading retailers throughout the United States," said Perry Antelman, CEO of Abacus. "In particular, the fact that CBDMEDIC™ products are now being positioned in-line demonstrates the acceptance of our over-the-counter products within the traditional pain relief and skincare categories and we look forward to seeing the continued growth in the number of retail locations in which CBDMEDIC™ is available."
A range of products within the CBDMEDIC™ line are now available in Harmon, Bed Bath & Beyond, Giant Eagle, URM Stores, Road Runner Sports, Fruth Pharmacy, Hartig, and Dierbergs retail stores. In total, these chains account for over 400 store locations in which CBDMEDIC™ products are available in the United States.
In total, purchase orders received to date for CBDMEDIC™ products represent availability in 15 retail and pharmacy chains and approximately 2,200 store locations in 11 states throughout the U.S.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) today announced it has received a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO) through which it will sell hemp-derived cannabidiol (CBD) infused personal care products in nearly 500 of its American Eagle (AE) stores and online.
The products, which were exclusively developed for American Eagle, include a wide assortment of CBD-infused personal care items such as lotions, muscle balms, and aromatherapy. Sales of the product are expected to begin in October 2019.
"We are very pleased to be partnering with American Eagle, a leader in the specialty retail space," said Green Growth Brands CEO, Peter Horvath. "GGB provided the expertise necessary to develop the product formulations and packaging to create a really special line of products."
All Green Growth Brands CBD products are sourced from U.S.-based, licensed hemp processors and comply with the 2018 Farm Bill. GGB sells and distributes topical CBD products only in jurisdictions that permit such sale.
Village Farms International, Inc. (TSX:VFF) (NASDAQ:VFF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has, on schedule, achieved full run-rate production of 75,000 kilograms of dried cannabis annually at its 1.1 million square foot Delta 3 greenhouse in Delta, B.C.
"With the benefit of Village Farms' 30-plus year track record of successfully developing and operating large-scale greenhouse facilities, Pure Sunfarms' ramp up to full production of premium, B.C.-grown cannabis has proceeded exceedingly well, and at a remarkable pace," said Michael DeGiglio, CEO Village Farms. "Quality, yield and cost of production at Pure Sunfarms' Delta 3 operation continues to meet or exceed our expectations, as they have since commercial production began last year. Importantly, with the advantage of the most experienced growing team in the industry and Village Farms' continued support, Pure Sunfarms' production output has not been impacted by crop issues as has been reported to be the case with other Canadian Licensed Producers. Pure Sunfarms is a best-in-class growing operation that is setting the standard for large-scale, high-quality cannabis production in Canada."
"We look forward to strong growth in revenue and profitability at Pure Sunfarms, driven by the successful ramp to full production at Delta 3. In addition, gross margin will benefit from the start of sales to the Ontario Cannabis Store and other potential retailers following Health Canada's expected near-term approval to sell directly to provincial/territorial and private retailers, as well as the transition of Pure Sunfarms' supply agreement with another licensed producer to more favorable terms on January 1, 2020."
Pure Sunfarms is one of the largest cannabis producers in the world and was profitable in both the fourth quarter of 2018 and first quarter of 2019, during both of which its Delta 3 greenhouse was ramping up and operating at well under full production.
Pure Sunfarms has commenced conversion of its second 1.1 million square foot greenhouse operation, Delta 2, for cannabis production, which will double Pure Sunfarms' annual output at full production to 150,000 kilograms. Pure Sunfarms expects to complete its first harvest at the Delta 2 facility by mid-2020, ramp to full run rate annual production by the fourth quarter of 2020, and operate at full production of 75,000 throughout 2021.
Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF) today announced that it has signed an agreement with 2103486 Alberta Ltd. operating as "ARBR" to incorporate NamasteMD into the ARBR clinical referral platform. ARBR is a web-based tool developed to help pharmacists and clinicians guide patients through their cannabis journey and support patients with questions or concerns, allowing them to select the right strain for their individual needs. The Edmonton, AB-based company has an agreement with one of Canada's largest generic pharmaceutical manufacturers whose customers include over 11,000 pharmacies across Canada.
Based on the agreement with ARBR, NamasteMD will act as a direct-connect telemedicine application to allow patients to immediately transition from the pharmacist's or clinician's consultation to a connection with a medical professional. Under the terms of the agreement, CannMart will be a preferred marketplace of choice given its large selection of LPs, strains, and other products.
"We continue to find innovative ways to expand our network and build the world's most customer focused cannabis marketplace," said Meni Morim, Interim CEO at Namaste Technologies. "We're leveraging in-house developed technology, like NamasteMD, to support tools like ARBR. This relationship opens a new channel to medical cannabis patients and allows the adult-use cannabis consumer to utilize their existing pharmacy relationships."
"Our goal is to provide a seamless transition from consulting a pharmacist about your cannabis needs, to being able to get a medical document and order product near instantaneously; with the added benefit of the largest selection of product possible," added Morim. "This agreement with a leading technology platform like ARBR continues to demonstrate our unique approach to the cannabis market and will help accelerate our growth."
"NamasteMD and the CannMart platform are a great way for pharmacists using our ARBR cannabis application to connect their customers with medical professionals and help service their customers' needs," said Kit Poon, CEO of ARBR. "We're excited to work with the team at Namaste to maximize the benefit from this relationship."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
